
    
      The program will offer twice yearly CA-125 blood tests and annual transvaginal ultrasounds to
      monitor women at high risk for ovarian cancer. In addition to the main purpose of providing
      ovarian cancer screening, the researchers would also like to build a repository of blood
      specimens for use in ovarian and breast cancer research and to offer genetics counseling
      sessions to help educate women about risk-reducing options.
    
  